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a b s t r a c t
Introduction: Fibromyalgia (FM) is a chronic pain condition that causes impaired functional 
capacity, possibly through the adoption of sedentary behaviour. However, little is known 
regarding physical activity level and its relationship with physical performance in women 
with FM. 
Objectives: To compare physical activity level, assessed using the International Physical 
Activity Questionnaire (IPAQ), and physical performance, measured using the six-minute 
walk test (6MWT), in women with and without FM and to examine the possible relation-
ships between physical activity level and physical performance in both groups.
Methods: The study included 30 women diagnosed with FM (patients) and 28 healthy wom-
en (controls) who answered the IPAQ and performed the 6MWT.
Results: Patients and controls self-reported similar physical activity level, considering both 
the total score and all IPAQ subcomponents (P > 0.05). However, the FM patients had worse 
physical performance in the 6MWT (patients, 441.8 ± 84.1 m vs. controls, 523.9 ± 80.3 m; P < 
0.01). There were no relationships between the distance walked in the 6MWT and the IPAQ 
variables for the control group. However, the distance walked by patients in the test showed 
a signifi cant correlation (P < 0.05) with the total score and the subcomponents transport, 
household activities, and physical activities of moderate intensity in the IPAQ.
Conclusions: Women with FM had physical activity levels similar to women without FM 
but exhibited worse physical performance. This functional impairment may be related to 
the lifestyle adopted because there was a relationship between physical activity level and 
physical performance in those patients.
© 2013 Elsevier Editora Ltda. All rights reserved.
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Nível de atividade física e desempenho físico no teste de caminhada de 6 
minutos em mulheres com fi bromialgia
Palavras-chave:
Dor crônica
Atividade motora
Aptidão física
Caminhada
r e s u m o
Introdução: A fi bromialgia (FM) é uma condição dolorosa crônica que causa comprometi-
mento da capacidade funcional, possivelmente pela adoção de um comportamento seden-
tário. No entanto, pouco se sabe sobre o nível de atividade física (NAF) e sua relação com o 
desempenho físico em mulheres com FM. 
Objetivos: Comparar o NAF, avaliado por meio do International Physical Activity Questio-
nnaire (IPAQ), e o desempenho físico, mensurado pelo teste de caminhada de 6 minutos 
(TC6) de mulheres com e sem FM, além de investigar possíveis relações entre NAF e desem-
penho físico em ambos os grupos.
Métodos: Participaram do estudo 30 mulheres com o diagnóstico de FM (pacientes) e 28 mu-
lheres saudáveis (controles) que responderam ao IPAQ e realizaram o TC6.
Resultados: Pacientes e controles autorrelataram similar NAF, considerando tanto o escore 
total quanto todos os subcomponentes do IPAQ (P > 0,05). Porém, as pacientes apresenta-
ram pior desempenho físico no TC6 (pacientes: 441,8 ± 84,1 m vs. controles: 523,9 ± 80,3 m; 
P < 0,01). Não existiram relações entre a distância caminhada no TC6 e as variáveis do IPAQ 
para o grupo controle. Entretanto, para as pacientes, a distância caminhada no teste apre-
sentou correlações signifi cativas (P < 0,05) com o escore total e com os subcomponentes 
transporte, atividades domésticas e atividades físicas de intensidade moderada do ques-
tionário IPAQ.
Conclusões: Mulheres com FM apresentaram NAF similar às mulheres sem FM, mas pior de-
sempenho físico. Esse comprometimento funcional pode estar relacionado ao estilo de vida 
adotado, uma vez que houve relação entre o NAF e o desempenho físico nessas pacientes.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Fibromyalgia (FM) is a rheumatic condition characterised by 
chronic widespread pain and a reduced pain threshold; this 
condition predominantly affects women.1 Some symptoms 
that are often associated with FM include fatigue, sleep dis-
orders and various somatic symptoms, which manifest at 
different intensities in each patient.2 Consequently, patients 
with FM commonly adopt sedentary behaviours, often result-
ing from fear caused by pain.
The increased pain intensity, associated with fear, indi-
cates to patients that they should discontinue the physical 
activity3 because it may compromise physical performance. 
Some studies have indicated that FM patients are less physi-
cally active than healthy individuals.4 The reduced physical 
activity level and increased sedentary behaviour contribute 
to maintaining or worsening the manifestations observed 
in FM,5,6 which may lead to a vicious cycle. Other impaired 
characteristics concern the patient’s physical fi tness. Physi-
cal inactivity, by itself, reduces certain physical/physiological 
parameters (muscle strength/endurance, aerobic capacity, 
fl exibility), irrespective of the disease or aging process, and 
increases patient risk for physical disabilities.7
Several studies have shown that FM patients have reduced 
physical performance when evaluated by simple tests or more 
complex and specifi c tests.8-12 However, simple and easily ap-
plied tests, which may be used as clinical parameters, must be 
performed to assess the effect of any intervention or to mea-
sure the functional condition. Therefore, the six-minute walk 
test (6MWT) is an option because it is a safe and inexpensive 
method13 that shows good applicability, considering that it 
globally evaluates the integration of responses of all physi-
ological systems involved during exercise.14 Although the 
6MWT has already been applied in previous studies involving 
FM patients with good reliability,15,16 research studies aimed 
at examining the relationship between physical activity level 
and physical performance in those patients are scarce.
The present study aimed to compare the physical activity 
level and physical performance of women with and without 
FM and to examine the possible relationships between physi-
cal activity level and physical performance in both groups.
Methodology
This descriptive and comparative cross-sectional study was 
approved by the Human Research Ethics Committee of the 
Department of Health Sciences, Universidade Federal do 
Paraná (UFPR, Curitiba, PR, Brazil), following the guidelines 
proposed in resolution 196/96 of the Brazilian National Health 
Council on research studies involving humans (CEP/SD regis-
tration number: 1161.086.11.06).
A total of 34 women diagnosed with FM, according to the 
criteria from the American College of Rheumatology, partici-
pated in the study.1 Recruitment occurred in two public hospi-
tals of Curitiba, PR, Brazil. The patients were invited to partici-
pate in the study following examination by rheumatologists 
when meeting the following inclusion criteria: aged between 
20 and 50 years and body mass index (BMI) between 18.5 and 
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39.9 kg/m2. The exclusion criteria established were the follow-
ing: heart diseases; untreated lung diseases; other rheumatic 
conditions; osteoporosis; severe musculoskeletal alterations; 
and the use of devices to perform their daily tasks. These data 
were gathered through self-reporting by study subjects and 
by monitoring their medical records. Four patients evaluated 
were excluded: three for not adequately fi lling in the IPAQ and 
one because she interrupted the 6MWT before completing the 
test. Thus, data from 30 patients were analysed. A total of 28 
women who were university staff and did not have an FM di-
agnosis were invited to comprise the control group. The se-
lection of the control group followed the same inclusion and 
exclusion criteria as the patients. 
After signing the informed consent form, all study subjects 
underwent anthropometric assessments to measure the body 
mass (digital scale) and height (wall-mounted stadiometer), 
according to the Anthropometric Standardization Reference 
Manual,17 to assess their BMI. Subsequently, they fi lled in the 
International Physical Activity Questionnaire (IPAQ), long ver-
sion, aimed at estimating their usual physical activity level.18 
This tool generates data regarding the frequency and length 
of activities, considering the last seven days, and measures 
the physical activity level related to various types of activi-
ties (work, transport, household chores, leisure) or different 
intensities (walks and physical activities with moderate or 
vigorous intensity). 
The physical performance of study subjects was measured 
using the 6MWT. The 6MWT was conducted in a 30-metre-
long fl at hallway, according to the American Thoracic Society 
guidelines.14 Each study subject performed one test, and the 
distance walked was recorded in metres at the end of each 
test.
For the statistical analyses, the Shapiro-Wilk test was ini-
tially used to assess data normality, and the Levene test was 
used to assess the homogeneity of variances when compar-
ing both groups. Pearson’s correlation and independent t tests 
were used for parametric data, and the Spearman’s Correla-
tion and Mann-Whitney U test were used for non-parametric 
data. The data were analysed using the STATISTICA software 
(STATSOFT Inc., version 7.0). The level of signifi cance was set 
at P < 0.05.
Results 
Table 1 shows the general sample characteristics. The two 
groups were similar regarding age and BMI. A comparison 
of the physical activity level between the patients and the 
healthy controls is shown in Table 2. No signifi cant differenc-
es were found for either overall physical activity level or the 
IPAQ subcomponents, indicating that the groups were similar 
with respect to active behaviour.
Fig. 1 shows that the distance covered while performing 
the 6MWT was signifi cantly different between the groups; the 
patients had a worse physical performance than the control 
group.
Correlation analyses were performed, and no signifi cant 
correlations were found in the patients for the variable dis-
tance in the 6MWT and the variables age (r = −0.11; P = 0.54) 
or BMI (r = −0.21; P = 0.25). The correlation analyses performed 
between the distances walked in the 6MWT and the variables 
related to physical activity are shown in Table 3. No signifi -
cant correlations were found in the control group. However, 
there was a positive correlation in the FM group between the 
distance walked and the time spent on activities related to 
active walking as a means of commuting, household activi-
ties, activities that require moderate intensities and overall 
Table 1 – Sample demographic and anthropometric 
characteristics.
Controls 
(n = 28)
Patients 
(n = 30)
P
Age (years) 40.7 ± 6.3 42.6 ± 5.8 0.17
Body mass (kg) 70.6 ± 13.1 72.4 ± 9.3 0.67
Height (cm) 160.7 ± 6.3 158.9 ± 5.3 0.25
BMI (kg/m2) 27.2 ± 5.1 28.7 ± 3.9 0.21
BMI, body mass index.
The data are expressed as the mean ± standard deviation. The 
independent t test and the Mann-Whitney U test were used to 
compare the groups when the variables showed parametric and 
nonparametric distribution, respectively.
Table 2 – The comparison of the level of physical activity between patients and healthy controls.
Controls (n = 28) Patients (n = 30) P
Mean ± SD Median Min-Max Mean ± SD Median Min-Max
IPAQ (total) 710.5 ± 619.7 510.0 130-2865  677.8 ± 632.7 417.5 50-2270 0.15
Work 145.1 ± 239.3 45.0 0-825  58.6 ± 103.1 0.0 0-360 0.84
Transport 88.2 ± 85.7 55.0 0-350  71.8 ± 54.1 72.5 0-200 0.71
Domestic 435.5 ± 505.7 227.5 0-2040  489 ± 600.5 242.5 0-1920 0.55
Leisure 41.6 ± 74.6 0 0-285  58.3 ± 87.8 0 0-360 0.12
Walk 149.8 ± 97.0 150.0 15-530  130.3 ± 121.4 100.0 0-435 0.54
Moderate PA 552.5 ± 608.8 372.5 0-2640  519.5 ± 610.5 257.5 0-1920 0.62
Vigorous PA 8.2 ± 29.6 0 0-150  28 ± 73.9 0 0-360 0.60
PA, physical activity.
The data are expressed as the mean ± standard deviation, median and range (minimum and maximum). Adopted measuring unit = minutes/
week. The total level of physical activity (total International Physical Activity Questionnaire, IPAQ) is generated by the sum of the subcomponents 
(work + transport + household + leisure) or the sum of the types of intensities (walking + moderate-intensity physical activity + vigorous-
intensity physical activity). The independent t test and the Mann-Whitney U test were used to compare the groups when the variables showed 
parametric and nonparametric distribution, respectively.
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physical activity level. The time spent on walks weekly also 
correlated better with performance in the 6MWT when the 
groups were combined.
Discussion
The ability to measure behaviour related to physical activity is 
especially useful for understanding the association between 
physical activity and health.19 In patients with FM, such data 
are required to enable designing interventions best suited 
to that population. Although these patients are presumably 
less physically active, the quantifi cation and characteriza-
tion of physical activity in FM patients are scarce, and most 
studies are recent. The fi ndings of the present study showed 
that patients and healthy controls did not differ with regard 
to their physical activity level when assessed using the IPAQ. 
While the results found in this study showed that the groups 
were similar with regard to the weekly time spent perform-
ing work, locomotion, in household and leisure activities and 
regarding the different intensities of physical activities, other 
studies4,20 have found different results using both indirect 
methods to assess physical activity levels such as the IPAQ 
and direc methods such as accelerometers.
The misperceptions that FM patients may have when re-
porting retrospective information concerning the time spent 
and the type of activities performed in recent days are among 
the factors that may explain such differences.4 The data re-
ported by those patients are usually overestimated compared 
with the data gathered using accelerometers, indicating a 
lack of association between the indirect and direct measures 
of assessment of physical activity levels.4,21 This suggests that 
self-reporting instruments fail to adequately capture the be-
haviour regarding physical activity in patients with FM.4 Al-
though it is not the only option available to assess the level 
of physical activity, self-reporting is a more practical and in-
expensive means for that purpose. The use of accelerometers 
faces some challenges, mainly related to the technology and 
its application,19 in addition to the cost of each unit, which 
limits their use. Pain intensity does not appear to be a limiting 
factor for the practice of physical activity because there is no 
apparent relation between pain and physical activity in those 
patients, despite differences in the literature on the compari-
son of physical activity levels between patients and healthy 
controls.4 However, it should be noted that the measurement 
and quantifi cation of physical activity levels in patients with 
FM is still little explored, which precludes further discussions 
on the topic.
Regardless of the method used to quantify physical ac-
tivity levels, encouraging patients with FM towards regu-
lar physical activity has been essential. Considering that 
physical exercise as non-pharmacological treatment for that 
population22 may help improve or maintain patients’ physi-
cal condition, its regular practice may presumably provide a 
greater feeling of overall wellness23 improving other symp-
toms associated with FM. Scientifi c evidence has shown 
the benefi ts, particularly of aerobic exercise on functional 
capacity and possibly on pain in FM.24 Fontaine et al.25 pro-
posed a study in which FM patients were encouraged to in-
crease the level of usual physical activity through several 
short sessions of moderate-intensity activities throughout 
the day, most days of the week, to improve FM symptoms. 
The intervention group reported decreased pain intensity 
compared with the control group (patients who were not 
encouraged to exercise). In the following study, the same 
researchers26 showed that the benefi ts acquired from that 
program were not sustained over time because the inter-
vention group signifi cantly decreased their physical activity 
level a few months after the intervention. Recent evidence 
involving the evaluation of physical activity and the central 
nervous system mechanism responsible for the processing 
and modulation pain through magnetic resonance imaging 
suggests that patients who are physically active and avoid 
sustained periods of sedentary behaviour appear to more 
adequately retain this ability to modulate pain  than those 
less active or who spend most of their time in sedentary 
activities.6,20 These data indicate that the regular practice of 
physical activity is important to promote improvements in 
the manifestations observed in FM. The habit of adopting an 
active lifestyle is perceived and emphasised by the patients 
themselves. In a survey conducted online on the patients’ 
Fig. 1 – The physical performance of controls and patients 
in the 6MWT. An independent t test was used to compare 
the groups.
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Table 3 – The correlation between distance walked in 
the 6MWT and physical activity level.
Patients Controls Combined
IPAQ (total) 0.40* 0.36 0.37*
Work 0.24 0.01 0.21
Transport 0.38* 0.23 0.28*
Domestic 0.41* 0.16 0.28*
Leisure 0.04 0.33 0.10
Walk 0.26 0.20 0.28*
Moderate PA 0.42* 0.24 0.35*
Vigorous PA 0.13 0.24 0.10
PA, physical activity.
* Indicates a signifi cant correlation at a level of P < 0.05. The 
correlations were performed for both groups assessed and 
combining both groups (controls + patients). Pearson’s correlation 
and Spearman’s correlation were used when variables showed 
parametric and nonparametric distribution, respectively.
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level of knowledge regarding the disease, the questions with 
the highest rates of correct answers addressed issues related 
to physical activity and/or exercise.27
The comparison of physical performance in both groups 
evaluated in the present study showed that the FM group had 
worse physical performance than the healthy control group. 
The distance walked during the 6MWT for patients and con-
trols and the magnitude of the difference found between 
groups were similar to those found in other studies conduct-
ed in Brazil28,29 and abroad.30,31 Furthermore, both groups had 
similar age, BMI and physical activity levels, which indicates 
that those factors had no direct effect on the performance 
in the 6MWT in one group or the other. Conversely, Manner-
korpi et al.32 found a direct relationship between the distance 
walked in the 6MWT and lower limb muscle strength in wom-
en with FM. Recently, Homann et al.33 showed that women 
with FM report a greater pain intensity and perception of 
effort while performing the 6MWT than healthy women at 
all times during the test. Exacerbation of pain and effort, es-
pecially at the end of the test, was also identifi ed in women 
with FM,33 which indicates that those factors may limit per-
formance in the 6MWT.
Various factors may presumably affect physical and func-
tional capacity in certain conditions where there is health 
limitation including age, BMI, physical and psychological fac-
tors and specifi c characteristics of the disease. In the case of 
FM, the main manifestations observed and the disease sever-
ity show a relationship with physical performance compro-
mise and the self-reporting of performing daily tasks.11,34,35 
However, behavioural factors that may be changed – includ-
ing the effect of physical activity levels or a patient’s status 
as sedentary, slightly or very active with respect to physical 
performance – are poorly addressed in FM patients.
In the present study, although women with and without 
FM exhibited no differences regarding the level of total phys-
ical activity and different types and intensities of activities 
performed, the group of patients with FM showed reduced 
physical performance. However, factors including age and 
BMI showed no signifi cant correlations with the distance 
walked during the 6MWT for either patients or controls. 
Thus, those two variables, which often limit performance on 
6MWT and are used in different equations to predict the dis-
tance walked, apparently do not limit the test performance. 
The analysis of possible relationships between physical 
activity levels and distance walked showed no signifi cant 
correlations in the control group. However, signifi cant cor-
relations, from weak to moderate, were found in the FM pa-
tient group. These data suggest that the time spent weekly 
on physical activities including locomotion and household 
activities, activities requiring moderate intensities and the 
total level of physical activity may be related to physical per-
formance in the 6MWT in patients with FM; that is, low per-
formance in the 6MWT may be indicative of reduced physi-
cal activity levels. Jones et al.34 also found that the level of 
physical activity affected the performance in the 6MWT in 
patients with FM.
The main limitation of the present study was the use of 
self-reported data to measure the level of physical activity. 
However, more refi ned and precise techniques remain an ob-
stacle for that purpose. Furthermore, other conditions typi-
cal of FM, which could generate further data and establish 
more accurate relations on what was evaluated in the present 
study, were not evaluated.
In summary, the fi ndings of the present study showed that 
women with FM self-reported physical activity levels similar 
to healthy women. However, the patients had worse physi-
cal performance in the 6MWT, which may have been affected 
by the physical activity levels because there were signifi cant 
correlations for distance walked in the test with some types 
of activities and the total level of physical activity reported 
by those patients. This information may be useful when pre-
scribing a treatment focused on maintaining and improving 
physical fi tness to avoid progressive losses of physical func-
tion in patients with FM.
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